GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Nuwellis Inc.
Nuwellis is a manufacturer of ultrafiltration medical devices. Its stock price reflects demand for its technology for treating fluid overload in patients with heart failure.
Share prices of companies in the market segment - Therapeutic medical equipment
Nuwellis, Inc. is a medical device company that has developed an ultrafiltration system for removing excess fluid in patients with heart and kidney failure. We've categorized it as "Therapeutic Medical Equipment." The chart below shows the dynamics of the therapeutic device sector.
Broad Market Index - GURU.Markets
Nuwellis is a medical device company that produces ultrafiltration systems that help remove excess fluid in patients with heart and kidney failure. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the medical device sector.
Change in the price of a company, segment, and market as a whole per day
NUWE - Daily change in the company's share price Nuwellis Inc.
For Nuwellis, Inc., a MedTech company, daily volatility reflects the sensitivity of its ultrafiltration system sales. This metric is an indicator of demand for its cardiology and critical care solutions.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Nuwellis develops and markets ultrafiltration systems for the removal of excess fluid in patients with heart and kidney failure. This is a niche medical device sector. The chart below shows the average volatility in this industry, allowing one to assess how the market perceives NUWE's technology.
Daily change in the price of a broad market stock, index - GURU.Markets
Nuwellis produces medical devices for ultrafiltration in patients with fluid overload. The medtech company's stock performance depends on the implementation of its technology in hospitals. Such unique stories are part of a larger market whose overall volatility you can see.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Nuwellis Inc.
Nuwellis, Inc.'s year-over-year performance tells the story of its performance in the ultrafiltration market. Its 12-month market cap growth reflects demand for its Aquadex FlexFlow® system, which is used in hospitals to remove excess fluid from patients with heart failure, its core, yet niche, area.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Nuwellis, Inc. is a commercial medical device company specializing in ultrafiltration for the treatment of fluid overload. This chart illustrates how its niche technology, market expansion efforts, and reliance on physician adoption of its method influence its performance in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Nuwellis, with its system for treating fluid overload, demonstrates how a small medical technology company is carving out its niche. Its ability to outperform the market depends on sales growth and convincing hospitals of the effectiveness of its therapy for patients with heart and kidney failure.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Nuwellis Inc.
Nuwellis is a commercial medical device company that produces ultrafiltration systems. Its monthly growth is driven by sales growth of its fluid overload treatment devices. Quarterly revenue reports are a key indicator.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
The market for medical devices for fluid management in critically ill patients is an important niche in the hospital sector. Its market capitalization dynamics, shown in the graph, reflect hospital demand. Companies like Nuwellis offer systems in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Nuwellis, a manufacturer of ultrafiltration systems, is betting on innovation in medical technology. The company's shares are driven by news of its technology being implemented in hospitals rather than by general market trends, creating an independent profile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Nuwellis Inc.
Nuwellis, a company that produces a medical device for removing excess fluid in patients with heart failure, operates in a niche but important market. Its weekly stock price reflects the pace of hospital adoption of its technology and the clinical data supporting its effectiveness.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Nuwellis has developed a system for removing excess fluid in patients with heart failure. This is a crucial tool in cardiology. The chart below shows how the company's stock compares to major players in the cardiology medical equipment sector and how sales data impacts it.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Nuwellis has developed a system for removing excess fluid from patients. This is a crucial tool in cardiology. The chart below shows how the company's stock compares to major medical device companies and the broader market.
Market capitalization of the company, segment and market as a whole
NUWE - Market capitalization of the company Nuwellis Inc.
Nuwellis's market capitalization chart reflects investors' valuation of its medical system for removing excess fluid from the body. Its dynamics reflect its efforts to promote its Aquadex FlexFlow device for treating heart failure patients. Its low price highlights the challenges of commercializing specialized medical equipment.
NUWE - Share of the company's market capitalization Nuwellis Inc. within the market segment - Therapeutic medical equipment
Nuwellis (formerly CHF Solutions) produces an ultrafiltration medical device that removes excess fluid from the body. Its market share is small, but it targets patients with heart failure. Its market capitalization reflects its niche but important role in treating fluid overload.
Market capitalization of the market segment - Therapeutic medical equipment
This chart shows the total market capitalization of the entire therapeutic medical device market. For Nuwellis, with its system for removing excess fluid from the body, this line represents the treatment of heart failure. The chart's growth reflects the aging population and the growing need for medical devices to manage the symptoms of chronic diseases.
Market capitalization of all companies included in a broad market index - GURU.Markets
Nuwellis produces ultrafiltration medical devices that help remove excess fluid in patients with heart failure. Its market cap reflects the valuation of its niche but vital technology.
Book value capitalization of the company, segment and market as a whole
NUWE - Book value capitalization of the company Nuwellis Inc.
Nuwellis developed an ultrafiltration system to remove excess fluid in patients with heart failure. Its book value is derived from its technological assets: patents for the Aquadex FlexFlow system and inventory of finished devices. This is its material foundation. How has this changed? The chart below shows.
NUWE - Share of the company's book capitalization Nuwellis Inc. within the market segment - Therapeutic medical equipment
Nuwellis, Inc. manufactures ultrafiltration systems for the treatment of fluid overload. Its business relies on manufacturing facilities for the assembly of its Aquadex SmartFlow consoles. The chart shows the company's share of the physical infrastructure for the production of specialized medical equipment.
Market segment balance sheet capitalization - Therapeutic medical equipment
Nuwellis is a medical technology company. This sector, as the chart shows, is capital-intensive. Nuwellis has developed a unique ultrafiltration system and has invested in the R&D and production of this complex device.
Book value of all companies included in the broad market index - GURU.Markets
Nuwellis' assets include manufacturing facilities for ultrafiltration (aquapheresis) systems, which are used in hospitals to remove excess fluid from patients with heart failure. Its book value reflects its industrial potential in this cardiology niche.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Nuwellis Inc.
Nuwellis is a medical device company specializing in the treatment of excess fluid in the body. Its market capitalization is based on its unique ultrafiltration system and its potential for treating patients with heart failure.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Nuwellis produces a medical device for removing excess fluid in patients with heart failure. The chart shows how investors view this technology and its potential to carve out a niche in the cardiovascular treatment market.
Market to book capitalization ratio for the market as a whole
Nuwellis produces medical devices for fluid ultrafiltration for the treatment of patients with fluid overload. This is a niche medical technology. This chart helps assess how the market views companies offering solutions to specific but important medical problems.
Debts of the company, segment and market as a whole
NUWE - Company debts Nuwellis Inc.
Nuwellis, a company that produces ultrafiltration systems for patients with fluid overload, uses capital to fund its sales and marketing. This chart illustrates the financial challenges a small medical device company faces as it seeks widespread clinical adoption of its technology.
Market segment debts - Therapeutic medical equipment
Nuwellis (formerly CHF Solutions) has developed an ultrafiltration system that helps remove excess fluid in heart failure patients. This chart shows how the medical technology company is funding the commercialization of its niche device, aiming to prove its effectiveness and convince hospitals of its necessity.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Nuwellis Inc.
Nuwellis (formerly CHF Solutions) produces an ultrafiltration medical device that helps remove excess fluid in patients with heart failure. Commercializing such complex medical equipment requires significant investment. This chart shows how the company uses debt to finance production, sales, and marketing.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Nuwellis produces an ultrafiltration medical device that helps remove excess fluid in heart failure patients. This chart shows how the company finances its production and sales. It compares its debt load to the market capitalization of the entire medical device sector.
Debt to book value of all companies in the market
Nuwellis, Inc. (formerly CHF Solutions) has developed a system for removing excess fluid in patients with heart failure. The medical device market is highly competitive. How reliant is the company on debt to finance sales and further development? This chart of total market debt helps evaluate its financial strategy.
P/E of the company, segment and market as a whole
P/E - Nuwellis Inc.
Nuwellis (formerly CHF Solutions) produces a medical device for removing excess fluid in patients with heart and kidney failure. This chart shows how investors value the device in the niche medical market. The valuation depends on sales growth and physician adoption of its technology.
P/E of the market segment - Therapeutic medical equipment
Nuwellis, Inc. is a medical technology company specializing in ultrafiltration for removing excess fluid in patients with heart and kidney failure. This chart illustrates the average valuation in the therapeutic medical device sector, which values technologies for treating critical conditions.
P/E of the market as a whole
Nuwellis, Inc. is a medical technology company that has developed an ultrafiltration system for removing excess fluid in patients with heart and kidney failure. This chart reflects the overall sentiment in the medical technology sector. It helps us understand whether NUWE's valuation reflects faith in its life-saving technology or whether it is moving in line with broader industry trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Nuwellis Inc.
Nuwellis, Inc., formerly CHF Solutions, manufactures an ultrafiltration medical device that helps remove excess fluid in patients with heart and kidney failure. This chart shows how the market estimates future demand for this therapy and the company's ability to expand its clinical application.
%20P%2FE%20Nuwellis%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Nuwellis-Inc.&v=1772513836563 "Chart of the company's future (projected) P/E Nuwellis Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Nuwellis is a medical device company specializing in ultrafiltration for the treatment of patients with fluid overload, often associated with heart failure. The chart reflects future revenue forecasts for the sector, helping to understand the market's confidence in the demand for this therapeutic technology in cardiology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772513836568 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Nuwellis, Inc. produces ultrafiltration medical equipment that helps remove excess fluid in patients with heart and kidney failure. This chart of overall sentiment in the medtech sector reflects investor confidence in the potential of technologies that solve important clinical problems.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513836600 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Nuwellis Inc.
Nuwellis, Inc. (formerly CHF Solutions) produces an ultrafiltration medical device that helps remove excess fluid in patients with heart failure. Profits are driven by sales of this system to hospitals. This chart shows the financial results of a company focused on treating one of the most serious symptoms of serious illnesses.
Profit of companies in the market segment - Therapeutic medical equipment
Nuwellis, Inc. specializes in the development and commercialization of ultrafiltration systems that help remove excess fluid in patients with heart and kidney failure. This chart shows the overall profitability of the therapeutic medical device sector, where innovative fluid overload treatments can improve patient outcomes.
Overall market profit
Nuwellis, Inc. manufactures medical devices for ultrafiltration in the treatment of fluid overload. Demand for its technology is driven by the clinical needs of patients with heart and kidney failure. This market is not dependent on economic cycles, as the need for treatment of these conditions is constant.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Nuwellis Inc.
Nuwellis, Inc. has developed and markets an ultrafiltration system for removing excess fluid in patients with heart failure. Future revenue depends on the acceptance of this therapy by hospitals and physicians. This chart reflects analyst expectations for its niche but important medical device.
%20profit%20of%20the%20company%20Nuwellis%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Nuwellis-Inc.&v=1772513836663 "Graph of future (projected) profit of the company Nuwellis Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Nuwellis (formerly CHF Solutions) has developed an ultrafiltration system that helps remove excess fluid in patients with heart and kidney failure. It is an essential tool for treating fluid overload. This graph shows profitability expectations for the therapeutic medical device sector, helping to evaluate Nuwellis' technology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772513836689 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Nuwellis, Inc. produces ultrafiltration medical devices that help remove excess fluid from the body. Demand for its products depends on hospital budgets. This economic outlook impacts the financial health of healthcare systems and their ability to purchase specialized equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513836706 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Nuwellis Inc.
Nuwellis produces a medical device for ultrafiltration for patients with fluid overload. Revenue growth reflects hospital adoption of this therapy. This chart shows how investors view its specialized product and its role in treating heart and kidney failure.
P/S market segment - Therapeutic medical equipment
Nuwellis is a medical technology company focused on treating patients with fluid overload. Their Aquadex SmartFlow ultrafiltration system offers a safe and effective alternative to diuretics for heart and kidney failure. This chart shows the average revenue estimate for the sector, helping to assess how the market views this important technology.
P/S of the market as a whole
Nuwellis is a medical technology company that has developed an ultrafiltration system for removing excess fluid in patients with heart and kidney failure. This graph, which displays average revenue estimates, helps understand how investors value the company, whose device solves a critical problem in healthcare.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Nuwellis Inc.
Nuwellis (formerly CHF Solutions) develops and markets an ultrafiltration medical device that removes excess fluid from the bodies of patients with heart failure. Its future revenue valuation is important to the company, reflecting investor expectations for the increased use of its therapy in hospitals as an effective treatment for fluid overload, a serious problem.
%20P%2FS%20Nuwellis%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Nuwellis-Inc.&v=1772513836827 "The graph of the company's future (projected) P/S Nuwellis Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Nuwellis is a medical device company specializing in treating patients with fluid overload using its ultrafiltration system. This chart compares the company's estimated future sales with expectations for the medical device sector. It shows whether investors believe in the clinical value of its therapy for patients with heart and kidney failure.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772513836848 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Nuwellis has developed a system for removing excess fluid from the body in patients with heart failure. The company's growth depends on hospitals adopting its technology as an effective treatment. This graph of investor expectations reflects their belief that medical devices can significantly improve the treatment of chronic diseases.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513836862 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Nuwellis Inc.
For Nuwellis, Inc., this figure reflects revenue from sales of its Aquadex ultrafiltration system, which is used in hospitals to remove excess fluid from patients with heart failure. Revenue growth depends on the adoption of this technology in clinical practice.
Sales of companies in the market segment - Therapeutic medical equipment
Nuwellis, Inc. (formerly CHF Solutions) manufactures the Aquadex FlexFlow medical device for removing excess fluid in patients with heart failure and other conditions. Its revenue breakdown shows how much of its revenue comes from sales of the device itself and how much from disposable consumables.
Overall market sales
Nuwellis, Inc. produces an ultrafiltration medical device that helps remove excess fluid in patients with heart failure. This overall economics does not impact demand for life-saving medical procedures for critically ill patients, which is Nuwellis' primary market.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Nuwellis Inc.
Nuwellis, Inc. (formerly CHF Solutions) produces a medical ultrafiltration device used to remove excess fluid in patients with heart and kidney failure. Sales growth depends on the adoption of this therapy in hospitals. This chart shows analysts' expectations for demand for its Aquadex SmartFlow system.
%20sales%20of%20the%20company%20Nuwellis%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Nuwellis-Inc.&v=1772513836926 "Schedule of future (projected) sales of the company Nuwellis Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Nuwellis, Inc. has developed a system for removing excess fluid in patients with heart and kidney failure. This chart shows the forecast for the therapeutic medical equipment market. Is demand growing for devices to treat conditions that are difficult to treat with medication? This reflects general trends.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772513836929 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Nuwellis produces a medical device for removing excess fluid in patients with heart failure. Demand for its products is driven by clinical needs and hospital budgets. This general economic activity pattern influences healthcare funding, but the need to treat severe conditions keeps demand relatively stable.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513836944 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Nuwellis Inc.
Nuwellis (formerly CHF Solutions) has developed and markets an ultrafiltration system that helps remove excess fluid in patients with heart failure. This chart shows the company's success in commercializing its medical device. Profitability depends on its adoption in hospitals and proof of its clinical and cost-effectiveness.
Market segment marginality - Therapeutic medical equipment
Nuwellis, Inc. (formerly CHF Solutions) produces an ultrafiltration medical device used to remove excess fluid in patients with heart failure. The company's profitability depends on sales of its system to hospitals and its acceptance by physicians as an effective treatment method. This metric reflects its commercial efforts.
Market marginality as a whole
Nuwellis, Inc. specializes in ultrafiltration devices, helping patients with fluid overload. Its success depends on the adoption of this technology in hospitals for the treatment of heart failure. This overall profitability chart reflects the financial health of the healthcare system and its ability to purchase specialized medical equipment.
Employees in the company, segment and market as a whole
Number of employees in the company Nuwellis Inc.
Nuwellis (formerly CHF Solutions) has developed and markets an ultrafiltration system for patients with fluid overload. Its small staff includes engineers and a sales team. This chart shows how the company manages its resources to promote its niche medical device to hospitals and physicians treating heart failure.
Share of the company's employees Nuwellis Inc. within the market segment - Therapeutic medical equipment
Nuwellis is a medical device company specializing in treating fluid overload in patients with heart and kidney failure using its therapeutic system. Commercializing this equipment requires a team of engineers and clinical support specialists. This chart shows the company's market share, reflecting its commercial reach and engineering potential.
Number of employees in the market segment - Therapeutic medical equipment
Nuwellis, Inc. has developed an ultrafiltration system for removing excess fluid in patients with heart failure and kidney failure. The chart reflects employment in the therapeutic medical equipment sector. The Aquadex FlexFlow device is an important tool for treating patients with fluid overload.
Number of employees in the market as a whole
Nuwellis produces ultrafiltration medical devices that help patients with fluid overload. The company's growth depends on hospitals adopting its technology. This chart illustrates the overall picture, and Nuwellis is an example of a MedTech company, where job creation is driven by the development and sale of equipment that improves patient care.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Nuwellis Inc. (NUWE)
Nuwellis (NUWE) produces the Aquadex SmartFlow system for ultrafiltration (removal of excess fluid) in patients with fluid overload. They are a specialized medical technology company. This chart shows how the market values their product. It reflects the market value per employee, which is a measure of the value of their IP and their commercial team.
%20of%20the%20company%20Nuwellis%20Inc.%20(NUWE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Nuwellis-Inc.-NUWE&v=1772513837029 "Chart of market capitalization per employee (in thousands of dollars) of the company Nuwellis Inc. (NUWE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Nuwellis (NUWE) produces the Aquadex FlexFlow ultrafiltration system, which is used to remove excess fluid in patients with heart failure. In the medical device industry, this parameter reflects the clinical significance of their device. The high capitalization per employee may indicate that their system is life-saving for patients who do not respond to diuretics.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772513837051 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Nuwellis produces a medical device for removing excess fluid in patients with heart failure. This figure reflects the value of its niche technology. The market is evaluating this device's ability to help patients who are unresponsive to standard drug therapy, creating a significant medical need.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513837063 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Nuwellis Inc. (NUWE)
Nuwellis (formerly CHF Solutions) is a MedTech company that manufactures a medical device (Aquadex) for ultrafiltration (removal of excess fluid) in patients with heart failure. This chart shows how successfully the company is selling its device. Revenue per employee is the margin earned on each device and consumables sold.
%20Chart%20Nuwellis%20Inc.%20(NUWE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Nuwellis-Inc.-NUWE&v=1772513837072 "Company Profit Per Employee (in thousands of dollars) Chart Nuwellis Inc. (NUWE)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Nuwellis, Inc. (formerly CHF Solutions) develops ultrafiltration systems for the removal of excess fluid in patients with heart failure. In the life-support medical device industry, the efficiency per employee reflects the demand for their technology. The graph shows how successfully the company is commercializing its specialized devices.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772513837073 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Nuwellis (NUWE) is a medical technology company focused on treating fluid overload in heart failure patients. They produce the Aquadex FlexFlow system. This is a B2B business for hospitals. This chart helps illustrate how profitable the specialized medical equipment business is per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513837077 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Nuwellis Inc. (NUWE)
Nuwellis, Inc. manufactures medical devices for ultrafiltration (removing excess fluid from the body). This chart shows the commercial success of their specialized equipment. The increase in revenue per employee indicates strong demand from hospitals for the treatment of patients with heart and kidney failure.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Nuwellis-Inc.-NUWE&v=1772513837087 "Sales chart per company employee Nuwellis Inc. (NUWE)")
Sales per employee in the market segment - Therapeutic medical equipment
Nuwellis (NUWE) (formerly CHF Solutions) is a medical technology company that produces the Aquadex SmartFlow system. It's a device for ultrafiltration (removing excess fluid) in patients with heart failure. This graph shows the average production in the sector. For NUWE, this is an indicator of how productive their R&D and sales teams are in promoting this niche hospital equipment.
Sales per employee for the market as a whole
Nuwellis (NUWE) is a medical technology company. Their Aquadex SmartFlow device is designed for ultrafiltration—removing excess fluid—in patients with heart failure. This indicator demonstrates the effectiveness of their model (selling hardware and consumables).
Short shares by company, segment and market as a whole
Shares shorted by company Nuwellis Inc. (NUWE)
Nuwellis (NUWE), formerly CHF Solutions, produces a medical device for ultrafiltration (removal of excess fluid) in patients with heart failure. This chart shows the volume of bearish bets. Shorts may reflect doubts about the device's effectiveness over standard diuretics.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Nuwellis-Inc.-NUWE&v=1772513837112 "Short Shares Chart for the Company Nuwellis Inc. (NUWE)")
Shares shorted by market segment - Therapeutic medical equipment
Nuwellis (NUWE) produces the Aquadex SmartFlow medical device, designed for ultrafiltration (removal of excess fluid) in patients with heart failure. This chart shows the overall short position in the medical device sector, highlighting investor concerns about the slow adoption of this therapy.
Shares shorted by the overall market
Nuwellis produces ultrafiltration systems for patients with fluid overload (edema), often in intensive care units. This chart measures general fear. When investors are fearful, they may worry that hospitals will cut back on niche equipment purchases during a recession. They also avoid illiquid medtech "microcaps" like NUWE, preferring sector giants.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Nuwellis Inc. (NUWE)
This chart shows the market reaction to Nuwellis' technology. The company produces ultrafiltration systems (Aquadex) for removing excess fluid in patients with heart and kidney failure. The "overbought" market (above 70) reflects rising sales of the devices. However, slow hospital adoption and competition from standard diuretics are leading to an "oversold" market.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Nuwellis-Inc.-NUWE&v=1772513837138 "RSI 14 indicator chart for the company's stock Nuwellis Inc. (NUWE)")
RSI 14 Market Segment - Therapeutic medical equipment
Nuwellis is a medical technology company specializing in blood ultrafiltration. Their Aquadex SmartFlow device is used in hospitals to remove excess fluid from patients with heart failure. This graph measures the overall momentum in the therapeutic medical equipment sector. It helps assess whether this entire innovative segment is overheating.
RSI 14 for the overall market
Nuwellis (NUWE) specializes in blood ultrafiltration devices, particularly for heart and kidney failure. Demand for medical technology is stable, but the company's valuation depends on the market climate. This chart shows when the overall market is in a state of euphoria (risk-taking) or panic (risk aversion). This impacts NUWE's ability to raise capital for growth and its stock valuation.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NUWE (Nuwellis Inc.)
Nuwellis is a medical technology company that produces the Aquadex ultrafiltration system. It helps doctors remove excess fluid (edema) from patients with heart failure who don't respond to diuretics. This chart shows the speculative average 12-month price target from analysts based on their belief in the adoption of this therapy.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NUWE-Nuwellis-Inc.&v=1772513837156 "A chart showing analyst consensus forecasts for the expected stock price. NUWE (Nuwellis Inc.)")
The difference between the consensus estimate and the actual stock price NUWE (Nuwellis Inc.)
Nuwellis is a medical technology company that developed the Aquadex system—an ultrafiltration system for blood used in patients with fluid overload (heart failure). This chart shows the difference between the market estimate and the consensus forecast. It reveals whether experts believe this "mechanical" diuretic therapy will be implemented in hospitals.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NUWE-Nuwellis-Inc.&v=1772513837159 "A chart showing the difference between the consensus forecast and the actual stock price. NUWE (Nuwellis Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Nuwellis is a medtech company focused on aquapheresis (Aquadex). Its device "filters" blood, removing excess fluid in patients with heart failure. This chart reflects analysts' overall expectations for the entire therapeutic medical device sector, demonstrating whether experts believe in this niche technology.
Analysts' consensus forecast for the overall market share price
Nuwellis is a medical device company that produces a system (Aquadex) that filters blood to remove excess fluid in patients with heart or kidney failure. This chart shows overall market sentiment. For Nuwellis, whose business is selling expensive hospital equipment, overall optimism (the rising chart) is important for funding and persuading hospitals.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Nuwellis Inc.
Nuwellis (formerly CHF Solutions) is a cardiac dialysis company. Their signature feature is their Aquadex system, which gently (unlike dialysis) removes excess fluid (water) from the blood of patients with heart failure. This chart is a summary of their razor and blade products. It reflects their (slow) ability to sell razors (machines) and their revenue from blades (consumables).
AKIMA Market Segment Index - Therapeutic medical equipment
Nuwellis specializes in fluid management. Their Aquadex system removes excess fluid in heart failure patients, often saving lives. It's a niche therapeutic device. This chart compares their composite index to the sector, showing how this vital but niche segment of medical technology stacks up against others.
The AKIM Index for the overall market
Nuwellis is a MedTech company specializing in ultrafiltration (the Aquadex system) for the treatment of fluid overload in heart failure. This chart, which reflects the market average, serves as a backdrop. It helps assess how NUWE, a niche solution for intensive care, compares to overall macroeconomic trends.
